Trivascular Technologies Inc (TRIV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,894 | 21,966 | 20,121 | 32,896 | 83,045 |
| Marketable Securities | 15,135 | 30,747 | 46,087 | 46,084 | N/A |
| Receivables | 6,600 | 6,804 | 6,149 | 6,565 | 4,897 |
| Inventories | 9,534 | 9,139 | 9,037 | 8,570 | 7,812 |
| TOTAL | $68,428 | $71,609 | $83,545 | $97,047 | $98,205 |
| Non-Current Assets | |||||
| PPE Net | 1,093 | 1,057 | 1,174 | 1,248 | 1,325 |
| Intangibles | 9,441 | 9,441 | 9,441 | 9,441 | 9,441 |
| Other Non-Current Assets | 832 | 753 | 774 | 797 | 695 |
| TOTAL | $11,366 | $11,251 | $11,389 | $11,486 | $11,461 |
| Total Assets | $79,794 | $82,860 | $94,934 | $108,533 | $109,666 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,780 | 2,970 | 3,695 | 1,862 | 1,778 |
| Accrued Expenses | 6,826 | 7,619 | 6,803 | 8,465 | 7,024 |
| TOTAL | $9,606 | $10,589 | $10,498 | $10,327 | $8,802 |
| Non-Current Liabilities | |||||
| Long Term Debt | 65,325 | 56,214 | 55,601 | 55,004 | 44,642 |
| Other Non-Current Liabilities | 3,335 | 3,382 | 3,505 | 3,629 | 3,753 |
| TOTAL | $68,660 | $59,596 | $59,106 | $58,633 | $48,395 |
| Total Liabilities | $78,266 | $70,185 | $69,604 | $68,960 | $57,197 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 20,571 | 20,520 | 20,503 | 20,384 | 20,369 |
| Common Shares | 204 | 204 | 202 | 202 | 200 |
| Retained earnings | -339,965 | -326,387 | -311,531 | -295,894 | -281,403 |
| Other shareholders' equity | -113 | -102 | -324 | -180 | -92 |
| TOTAL | $1,528 | $12,675 | $25,330 | $39,573 | $52,469 |
| Total Liabilities And Equity | $79,794 | $82,860 | $94,934 | $108,533 | $109,666 |